Clinical trial
Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples
NCT04251078 is registered in ClinicalTrials.gov with Josep Carreras Leukaemia Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples
- Lead sponsor
- Josep Carreras Leukaemia Research Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2019
- Completion date
- June 30, 2025
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.